These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23258115)

  • 1. Reinforced biographies among women living with hepatitis C.
    Olsen A; Banwell C; Dance P
    Qual Health Res; 2013 Apr; 23(4):531-40. PubMed ID: 23258115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs.
    Olsen A; Banwell C; Dance P; Maher L
    Int J Drug Policy; 2012 Jul; 23(4):312-8. PubMed ID: 22721571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.
    Treloar C; Rhodes T
    Qual Health Res; 2009 Sep; 19(9):1321-34. PubMed ID: 19690211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
    Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
    Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
    Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
    Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
    Crockett B; Gifford SM
    Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injecting drug users' understanding of hepatitis C.
    O'Brien S; Day C; Black E; Dolan K
    Addict Behav; 2008 Dec; 33(12):1602-5. PubMed ID: 18762384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection.
    Hopwood M; Treloar C
    Int J Drug Policy; 2007 Oct; 18(5):374-80. PubMed ID: 17854725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staying safe from hepatitis C: engaging with multiple priorities.
    Harris M; Treloar C; Maher L
    Qual Health Res; 2012 Jan; 22(1):31-42. PubMed ID: 21873284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
    Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
    Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception.
    Safo SA; Batchelder A; Peyser D; Litwin AH
    Harm Reduct J; 2015 Jun; 12():20. PubMed ID: 26092261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
    Treloar C; Hull P; Dore GJ; Grebely J
    Drug Alcohol Rev; 2012 Nov; 31(7):918-24. PubMed ID: 22612899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C.
    Waldby C; Rosengarten M; Treloar C; Fraser S
    Soc Sci Med; 2004 Oct; 59(7):1461-71. PubMed ID: 15246174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs.
    Davis M; Rhodes T; Martin A
    Soc Sci Med; 2004 Nov; 59(9):1807-18. PubMed ID: 15312916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding social stigma in women with hepatitis C.
    Grundy G; Beeching N
    Nurs Stand; 2004 Oct 6-12; 19(4):35-9. PubMed ID: 15521414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.
    Madden A; Hopwood M; Neale J; Treloar C
    Harm Reduct J; 2018 Aug; 15(1):42. PubMed ID: 30111327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
    Doab A; Treloar C; Dore GJ
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S313-20. PubMed ID: 15768340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.